Aspire Biopharma Holdings Inc. (ASBP)
NASDAQ
Closed
Aug 21, 2026
Day's Range
7.9052 wk Range
0.1100Overview - ASBP - Aspire Biopharma Holdings Inc.
Key Statistics
Valuation
Enterprise Value
-988.75K
P/E (Trailing)
‪-0.01‬
PEG Ratio
‪-0.00072‬
Price / Sales (TTM)
‪114.46‬
Price / Book
‪0.87‬
EV / EBITDA
‪0.06‬
Profitability
Gross Margin
‪20.28%‬
Profit Margin
‪-1.87%‬
Operating Margin
‪-3,880.58%‬
Return on Assets
‪60.57%‬
Return on Equity
‪-1,032.14%‬
Ownership
Shares Outstanding
167.47K
Float
1.11M
Short % of Shares Outstanding
‪6.22%‬
Held by Insiders
‪20.10%‬
Held by Institutions
‪3.36%‬
Price stats
Beta
‪0.11‬
50-Day Avg
‪6.61‬
200-Day Avg
‪3.92‬
Dividends
Payout Ratio
‪0.00%‬
Shariah Compliance
Report Date: Feb 18, 2025
Screened by Zoya using the AAOIFI methodology.
Market Cap - ASBP - Aspire Biopharma Holdings Inc.
Peers - ASBP - Aspire Biopharma Holdings Inc.
Peer Comparison
Compared with companies in Biotechnology listed on NASDAQ.
- ASBPNASDAQAspire Biopharma Holdings Inc.10.02MMarket Cap-142.91%52-week change-0.02P/E (Trailing)‪-1.87%‬Profit Margin
- ARGXNASDAQargenx SE American Depositary Receipt65.04BMarket Cap+34.86%52-week change39.69P/E (Trailing)‪32.26%‬Profit Margin
- ALNYNASDAQAlnylam Pharmaceuticals Inc31.60BMarket Cap-87.81%52-week change41.15P/E (Trailing)‪16.12%‬Profit Margin
- BNTXNASDAQBioNTech SE29.28BMarket Cap+9.87%52-week change160.80P/E (Trailing)‪-63.63%‬Profit Margin
- ASNDNASDAQAscendis Pharma A/S16.61BMarket Cap+24.84%52-week change19.38P/E (Trailing)‪70.84%‬Profit Margin
- BBIONASDAQBridgeBio Pharma, Inc.15.93BMarket Cap+41.98%52-week change-21.56P/E (Trailing)‪-97.02%‬Profit Margin
- BMRNNASDAQBiomarin Pharmaceutical Inc.12.91BMarket Cap+12.29%52-week change180.16P/E (Trailing)‪2.14%‬Profit Margin
Profile Summary - ASBP - Aspire Biopharma Holdings Inc.
About
Aspire Biopharma Holdings Inc. is an early-stage biopharmaceutical company focused on developing and marketing disruptive sublingual delivery technology for drugs and supplements. This patent-pending platform enables rapid absorption directly into the bloodstream through tissues under the tongue, bypassing the…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Shariah compliance data provided by Zoya. Charting by TradingView.
Last updated:
